INTERNATIONAL PATENT: AMICUS THERAPEUTICS, INC. FILES APPLICATION FOR "RECOMBINANT ALPHA-GALACTOSIDASE A PROTEINS AND GENE THERAPY"

GENEVA, Dec. 31 -- AMICUS THERAPEUTICS, INC. (3675 Market StreetPhiladelphia, Pennsylvania 19104) filed a patent application (PCT/US2025/034471) for "RECOMBINANT ALPHA-GALACTOSIDASE A PROTEINS AND GENE THERAPY" on Jun 20, 2025. With publication no. WO/2025/264978, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WILLER, Tobias (3675 Market StreetPhiladelphia, Pennsylvania 19104)

Abstract: A composition including a gene therapy delivery system and an alpha-galactosidase (GLA) polynucleotide encoding a GLA polypeptide, wher...